Agenda:
- The Changing Face of Patient Referral: From Clinical Studies to Commercial Programs - Naomi Fisher, MD
- Beyond the Pivotal Trial: Real-World Data Impact in Uncontrolled Hypertension - Karl Fengler, MD
- The Science of uRDN and Why Paradise System is My Choice for My Patients - Ajay Kirtane, MD
- From Policy to Practice: How Reimbursement is Shaping RDN Adoption - Matheen Khuddus, MD
FACULTY
![]() |
Naomi Fisher, MD |
![]() |
Ajay Kirtane, MD, SM |
![]() |
Matheen Khuddus, MD |
![]() |
Karl Fengler, MD |





